Literature DB >> 11773868

Ethnic differences in allelic frequency of two flavin-containing monooxygenase 3 (FMO3) polymorphisms: linkage and effects on in vivo and in vitro FMO activities.

Chang-Shin Park1, Ju-Hee Kang, Woon-Gye Chung, Hyun-Gyu Yi, Jae-Eun Pie, Dong-Kyun Park, R N Hines, D G McCarver, Young-Nam Cha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11773868     DOI： 10.1097/00008571-200201000-00011

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN： 0960-314X


× No keyword cloud information.
  11 in total

1.  Molecular phylogeny, long-term evolution, and functional divergence of flavin-containing monooxygenases.

Authors:  Da Cheng Hao; Shi Lin Chen; Jun Mu; Pei Gen Xiao
Journal:  Genetica       Date:  2009-07-05       Impact factor: 1.082

Review 2.  Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism.

Authors:  Sharon K Krueger; David E Williams
Journal:  Pharmacol Ther       Date:  2005-06       Impact factor: 12.310

3.  Population Pharmacokinetics of Sulindac and Genetic Polymorphisms of FMO3 and AOX1 in Women with Preterm Labor.

Authors:  Jin Won Sung; Hwi-Yeol Yun; Sunny Park; Young Ju Kim; Jeong Yee; Kyung Eun Lee; Byungjeong Song; Jee Eun Chung; Hye Sun Gwak
Journal:  Pharm Res       Date:  2020-01-28       Impact factor: 4.200

Review 4.  Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions.

Authors:  Slobodan P Rendić; Rachel D Crouch; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2022-06-01       Impact factor: 6.168

5.  Effects upon in-vivo nicotine metabolism reveal functional variation in FMO3 associated with cigarette consumption.

Authors:  A Joseph Bloom; Sharon E Murphy; Maribel Martinez; Linda B von Weymarn; Laura J Bierut; Alison Goate
Journal:  Pharmacogenet Genomics       Date:  2013-02       Impact factor: 2.089

Review 6.  Genetic polymorphisms of human flavin-containing monooxygenase 3: implications for drug metabolism and clinical perspectives.

Authors:  Irfan M Hisamuddin; Vincent W Yang
Journal:  Pharmacogenomics       Date:  2007-06       Impact factor: 2.533

7.  Effect of two-linked mutations of the FMO3 gene on itopride metabolism in Chinese healthy volunteers.

Authors:  Li-Ping Zhou; Zhi-Rong Tan; Hao Chen; Dong Guo; Yao Chen; Wei-Hua Huang; Lian-Sheng Wang; Guo-Gang Zhang
Journal:  Eur J Clin Pharmacol       Date:  2014-09-17       Impact factor: 2.953

8.  Effects of FMO3 Polymorphisms on Pharmacokinetics of Sulindac in Chinese Healthy Male Volunteers.

Authors:  Yong-Jun Tang; Kai Hu; Wei-Hua Huang; Chong-Zhi Wang; Zhi Liu; Yao Chen; Dong-Sheng Ouyang; Zhi-Rong Tan; Hong-Hao Zhou; Chun-Su Yuan
Journal:  Biomed Res Int       Date:  2017-02-26       Impact factor: 3.411

9.  Nicotine-N'-Oxidation by Flavin Monooxygenase Enzymes.

Authors:  Yadira X Perez-Paramo; Gang Chen; Joseph H Ashmore; Christy J W Watson; Shamema Nasrin; Jennifer Adams-Haduch; Renwei Wang; Yu-Tang Gao; Woon-Puay Koh; Jian-Min Yuan; Philip Lazarus
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-10-31       Impact factor: 4.254

10.  Fish odor syndrome (trimethylaminuria) supporting the possible FMO3 down expression in childhood: a case report.

Authors:  Rosalia D'Angelo; Concetta Scimone; Teresa Esposito; Daniele Bruschetta; Carmela Rinaldi; Alessia Ruggeri; Antonina Sidoti
Journal:  J Med Case Rep       Date:  2014-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.